DOCUMENT: SafeRx Formulary Guidelines 2024
Type: Internal Policy Document
Effective Date: January 1, 2024
Last Updated: December 15, 2023
Department: Pharmacy and Therapeutics Committee

============================================================

OVERVIEW
--------

This document establishes the SafeRx Formulary Guidelines for 2024. The formulary is a list of preferred medications selected based on clinical efficacy, safety, and cost-effectiveness. Healthcare providers should prescribe formulary medications when clinically appropriate.

FORMULARY TIERS
---------------

Tier 1 - Preferred Generic Medications (Lowest Copay)
- Metformin (diabetes - first line)
- Lisinopril (hypertension - first line ACE inhibitor)
- Amlodipine (hypertension - first line calcium channel blocker)
- Atorvastatin (cholesterol - first line statin)
- Omeprazole (GERD - first line PPI)
- Sertraline (depression/anxiety - first line SSRI)
- Metoprolol (heart rate control - first line beta blocker)
- Levothyroxine (hypothyroidism)
- Gabapentin (neuropathic pain)
- Hydrochlorothiazide (hypertension - first line diuretic)

Tier 2 - Preferred Brand Medications (Medium Copay)
- Brand-name medications with no generic equivalent
- Specialty medications requiring prior authorization
- Combination products when clinically indicated

Tier 3 - Non-Preferred Medications (Highest Copay)
- Medications with preferred alternatives available
- Requires step therapy through Tier 1/2 first
- Prior authorization may be required

THERAPEUTIC SUBSTITUTION POLICY
-------------------------------

Automatic substitution is permitted for the following therapeutic classes:

1. ACE Inhibitors: Lisinopril is the preferred agent
   - Substitution from: enalapril, benazepril, ramipril, quinapril
   - Exception: patients stable on current therapy >6 months

2. Statins: Atorvastatin is the preferred agent
   - Substitution from: simvastatin, pravastatin, rosuvastatin
   - Exception: documented intolerance or drug interaction

3. PPIs: Omeprazole is the preferred agent
   - Substitution from: lansoprazole, pantoprazole, esomeprazole
   - Exception: treatment failure on omeprazole

4. SSRIs: Sertraline is the preferred agent for new starts
   - No automatic substitution for patients stable on other SSRIs
   - Consider fluoxetine for patients requiring liquid formulation

PRIOR AUTHORIZATION REQUIREMENTS
--------------------------------

The following medication classes require prior authorization:

1. Controlled Substances (Schedule II-IV)
   - Opioid analgesics (see Opioid Prescribing Policy)
   - Benzodiazepines (alprazolam, lorazepam, clonazepam)
   - Stimulants (amphetamines, methylphenidate)

2. High-Cost Medications
   - Biologics and biosimilars
   - Specialty injectables
   - Medications exceeding $1,000/month

3. Medications with Safety Concerns
   - Warfarin (requires INR monitoring documentation)
   - Methotrexate (requires appropriate diagnosis)
   - Isotretinoin (requires iPLEDGE enrollment)

QUANTITY LIMITS
---------------

Standard dispensing quantities:
- Acute medications: 10-14 day supply
- Maintenance medications: 30-90 day supply
- Controlled substances: 30 day supply maximum

Exceptions require clinical justification and supervisor approval.

GENERIC SUBSTITUTION REQUIREMENTS
---------------------------------

Generic substitution is mandatory unless:
1. Prescriber indicates "Dispense as Written" with clinical justification
2. Patient has documented allergy to generic inactive ingredients
3. Narrow therapeutic index drugs (warfarin, levothyroxine, anti-epileptics) where stability is established on brand

MEDICATION REVIEW TRIGGERS
--------------------------

Mandatory pharmacist review required for:
- Patients on 5+ chronic medications (polypharmacy)
- New prescriptions for high-alert medications
- Patients >65 years starting new CNS-active medications
- Any opioid prescription >90 MME/day

CONTACT INFORMATION
-------------------

For formulary questions or prior authorization:
- Pharmacy Helpline: Internal extension 5500
- P&T Committee: pharmacy.committee@saferx.internal
- Emergency formulary exceptions: On-call pharmacist

============================================================
Document ID: POL-FORM-2024-001
Classification: Internal Use Only
